← Leaderboards
Eric J Arts
Case Western Reserve University
$12,120,161
Attributed
$12,398,352
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,398,352 · 13
By mechanism
R01$7,506,853 · 3
P30$2,037,059 · 3
P01$1,779,735 · 4
R21$674,705 · 2
R56$400,000 · 1
Top collaborators
- Jonathan Karn1 shared
- Gabriele Varani1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Michael Marcel Lederman$51,371,852
- Lan Zhou$8,666,516
- Yong Gao$3,416,365
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseHiv-1InfectionAcuteVirusCellsFitnessDisease ProgressionWomanViralSamplingVaginaCervicalTransmission ProcessBloodGrantSiteUgandaGeneticT-LymphocyteCd4 Lymphocyte CountImmune ResponseMacrophageCd4 Positive T Lymphocytes
Grant awards (44)
Determinants of HIV transmission fitness$411,631
R01 · FY2024 · AI · contact PI
Determinants of HIV transmission fitness$411,631
R01 · FY2023 · AI · contact PI
Determinants of HIV transmission fitness$411,631
R01 · FY2022 · AI · contact PI
Determinants of HIV transmission fitness$411,631
R01 · FY2021 · AI · contact PI
Determinants of HIV transmission fitness$411,631
R01 · FY2020 · AI · contact PI
Impact of HIV-1 fitness on disease progression$343,027
R01 · FY2016 · AI · contact PI
Impact of HIV-1 fitness on disease progression$348,987
R01 · FY2015 · AI · contact PI
Impact of HIV-1 fitness on disease progression$347,410
R01 · FY2014 · AI · contact PI
Consequences of immune escape on viral fitness$150,596
P01 · FY2014 · AI · contact PI
Impact of HIV-1 fitness on disease progression$449,769
R01 · FY2013 · AI · contact PI
New Inhibitors of HIV replication$417,287
R01 · FY2013 · GM
Consequences of immune escape on viral fitness$335,259
P01 · FY2013 · AI · contact PI
Ugandan Laboratory Core$274,701
P30 · FY2013 · AI · contact PI
HIV-1 Fitness and Recombination$400,000
R56 · FY2012 · AI · contact PI
Consequences of immune escape on viral fitness$264,379
P01 · FY2012 · AI · contact PI
Ugandan Laboratory Core$228,126
P30 · FY2012 · AI · contact PI
Consequences of immune escape on viral fitness$376,558
P01 · FY2011 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$371,372
R01 · FY2011 · AI · contact PI
Ugandan Laboratory Core$244,545
P30 · FY2011 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$470,819
R01 · FY2010 · AI · contact PI
Consequences of immune escape on viral fitness$387,847
P01 · FY2010 · AI · contact PI
Ugandan Laboratory Core$235,776
P30 · FY2010 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$85,821
R01 · FY2010 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$378,911
R01 · FY2009 · AI · contact PI
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma$211,000
R21 · FY2009 · AI · contact PI
Ugandan Laboratory$113,447
P30 · FY2009 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$378,911
R01 · FY2008 · AI · contact PI
CORE--Ugandan Laboratory Core$238,342
P30 · FY2008 · AI · contact PI
New SHIV R5 env's (based on all subtypes) for effective microbicide testing in ma$198,250
R21 · FY2008 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$386,250
R01 · FY2007 · AI · contact PI
CORE--Ugandan Laboratory Core$233,485
P30 · FY2007 · AI · contact PI
CORE--Ugandan Laboratory Core$161,150
P30 · FY2006 · AI · contact PI
Impact of HIV-1 Fitness on Disease Progression$293,959
R01 · FY2005 · AI
CORE--Ugandan Laboratory Core$157,082
P30 · FY2005 · AI
Impact of HIV-1 Fitness on Disease Progression$294,310
R01 · FY2004 · AI
CORE--Ugandan Laboratory Core$150,405
P30 · FY2004 · AI
Impact of HIV-1 Fitness on Disease Progression$296,882
R01 · FY2003 · AI
Impact of HIV-1 Fitness on Disease Progression$296,460
R01 · FY2002 · AI
Core--Laboratory-Uganda$0
P01 · FY2002 · AI
Testing In Vitro Antiviral Activity of Novel Chemokine$0
P01 · FY2002 · AI
Impact of HIV-1 Fitness on Disease Progression$265,455
R21 · FY2001 · AI
HIV 1 RESISTANCE TO CHEMOKINE ANALOGS$0
P01 · FY2001 · AI
REVERSE TRANSCRIPTASE-PRIMER/TRNA INTERATIONS IN$288,523
R01 · FY2000 · AI
HIV 1 RESISTANCE TO CHEMOKINE ANALOGS$265,096
P01 · FY2000 · AI